|
|
 |
|
|
Since
1990, Corgenix, has established a reputation as a leader
in the antiphospholipid testing market. Corgenix
(formally REAADS Medical Products, Inc.) was the first
commercial company in the United States to develop and
receive FDA clearance to manufacture and market the
anti-cardiolipin assay used in the detection of a number
of autoimmune and vascular diseases. Since then, the
Corgenix product line has grown to include a number of
products that are distributed worldwide. These products are used in the
detection and evaluation of autoimmune disease,
hemostasis and thrombosis evaluation, and liver disease.
ANTI-PHOSPHOLIPID
PRODUCTS
AUTOIMMUNE
PRODUCTS
HEMOSTASIS PRODUCTS
GASTROENTEROLOGY
PRODUCTS
PLATELET
FUNCTION PRODUCTS
|
|
